NeuroImage Nord, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gerontology. 2011;57(4):354-63. doi: 10.1159/000322090. Epub 2010 Oct 26.
In recent years, the placebo effect has been a topic of considerable interest both in the scientific and the clinical community. In this time, the placebo effect has evolved from being considered a nuisance in clinical and pharmacological research to becoming a neurobiological phenomenon worthy of scientific investigation in its own right. Recent research shows that placebo effects are genuine psychobiological events attributable to the overall therapeutic context, and that these effects can be robust in both laboratory and clinical settings. These psychosocially induced biochemical changes in a patient's brain and body may in turn affect the course of a disease and the response to a therapy. Here we summarize and discuss the current insights into placebo mechanisms and discuss the potentially widespread implications for research and clinical practice. Even though a systematic knowledge of placebo effects across the lifespan is lacking, we aim at highlighting specific aspects related to the care of elderly patients and those suffering from neurodegenerative diseases.
近年来,安慰剂效应在科学界和临床界都引起了相当大的兴趣。在这段时间里,安慰剂效应已经从被认为是临床和药理学研究中的一个麻烦,演变成了一种值得科学研究的神经生物学现象。最近的研究表明,安慰剂效应是真实的心理生物学事件,归因于整体治疗环境,这些效应在实验室和临床环境中都很强大。这些由社会心理因素引起的患者大脑和身体中的生化变化反过来可能会影响疾病的进程和对治疗的反应。在这里,我们总结和讨论了目前对安慰剂机制的理解,并讨论了其对研究和临床实践的潜在广泛影响。尽管我们缺乏对整个生命周期内安慰剂效应的系统认识,但我们旨在强调与老年患者和患有神经退行性疾病的患者护理相关的特定方面。